LINKEDIN TWITTER PATIENTS & CAREGIVERS MEDICAL PROFESSIONALS CAREERS INVESTORS ABOUT US RESEARCH PIPELINE NEWS & EVENTS CONTACT US ABOUT US Leadership Jacqualyn Fouse, Ph.D. Chief Executive Officer Jonathan Biller Chief Financial Officer and Head of Legal and Corporate Affairs Bruce Car, Ph.D. Chief Scientific Officer Sarah Gheuens, M.D., Ph.D. Chief Medical Officer Melissa McLaughlin Chief People Officer Darrin Miles Chief Commercial Officer Clive Patience, Ph.D. EVP Technical Operations Board of Directors Paul Clancy Independent Ian Clark Independent Kaye Foster Independent Jacqualyn Fouse, Ph.D. Agios Pharmaceuticals Maykin Ho, Ph.D. Independent John Maraganore, Ph.D. Alnylam Pharmaceuticals David Scadden, M.D. Independent David Schenkein, M.D. Google Ventures Scientific Advisors Agios has assembled a world-class scientific advisory board that includes renowned experts in cancer metabolism, oncology, drug discovery and translational medicine. These advisors work in close collaboration with Agios scientists to identify new research directions and accelerate Agios’ target validation and drug discovery programs. Joan Brugge, Ph.D. Harvard Medical School Lewis C. Cantley, Ph.D. The Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital Ralph Deberardinis, M.D., Ph.D. Children's Medical Center Research Institute at UT Southwestern Tak Mak, Ph.D. University of Toronto and the Campbell Family Institute for Breast Cancer Research Charles Sawyers, M.D. Memorial Sloan-Kettering Cancer Center Shin-San Michael Su, Ph.D. Former SVP of Research and Development at Agios Marc Tessier-Lavigne, Ph.D. Stanford University Craig B. Thompson, M.D. Chair of the scientific advisory board, Memorial Sloan-Kettering Cancer Center Matthew Vander Heiden, M.D., Ph.D. Koch Institute for Integrative Cancer Research at MIT Scott Biller, Ph.D. Former Chief Scientific Officer at Agios Founders Lewis C. Cantley, Ph.D. Director of the Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital / read more / Tak Mak, Ph.D. Professor, University of Toronto; Director of the Advanced Medical Discovery Institute; Director of the Campbell Family Institute for Breast Cancer Research / read more / Shin-San Michael Su, Ph.D. Chief Scientific Officer at Decibel Therapeutics / read more / Craig B. Thompson, M.D. President and CEO of Memorial Sloan-Kettering Cancer Center / read more / Patients & Caregivers Our Commitment Investigational Medicines Clinical Trials Pyruvate Kinase Deficiency Patient Resources Medical Professionals Medical Professionals Careers Our Values Inside Agios Find a Job Benefits Commitment to Our Community Investors Overview Press Releases Events & Presentations Stock Information Financials Resources Contact Us About Us About Us Our Values Leadership Board of Directors Scientific Advisors Founders Our History Corporate Responsibility & Sustainability Research Our Research Platform Publications Pipeline Pipeline News & Events Press Releases Events & Webcasts Contact Us Contact Us © 2021 Agios, Inc. All rights reserved. Privacy Notice Cookie Preferences Copyright Info Terms of Use Compliance Sitemap Contact Us Do Not Sell My Personal Information Your Cookie Settings We use cookies and related technologies (“Cookies”) to provide services, gather information when users navigate through the sites, and to provide the best user experience when you visit our website. Some cookies are necessary for running our website while others are used for statistical purposes or for understanding usage patterns to enhance and personalize the experience. You can decline the use of non-essential cookies or decide which cookies should be allowed by changing your Cookies Settings, but please consider that some functionalities of the website may not be available based on your choices. By clicking “Accept All Cookies” you are agreeing to the placement of cookies. Privacy Notice Cookies Settings Decline Accept